LONDON (Reuters) - A 709 million euro-equivalent (564 million pounds) covenant-lite financing backing private equity firms Montagu and Astorg's acquisition of French medical diagnostics company Sebia ...

This partnership will enable the validation of new infectious and metabolic diagnostic tests that allow for earlier and more accurate identification of the severity of sepsis, enabling faster ...

Montagu Private Equity and Astorg Partners are considering a sale of French medical diagnostic equipment maker Sebia SA, which could be valued at more than 2 billion euros ($2.3 billion), people ...

Sebia, the world leader in medical diagnostics by capillary electrophoresis, has achieved the CE mark for its HbA1c capillary electrophoresis technique to be used for the diagnosis of diabetes.

Sebia has announced that it has entered into partnership with Inserm (the French National Institute of Health and Medical Research) and Inserm Transfert, its private subsidiary responsible for ...

Hemoglobinopathies are inherited single-gene disorders leading to production of abnormal hemoglobin or low hemoglobin. Approximately 7% of the global population are carriers and 2.7 per 1000 ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. London buyout house Cinven expects to get a price of more than €1bn for Sebia, a French medical diagnostics ...

TOULOUSE, France & FULLERTON, Calif. & LISSES, France, November 20, 2025--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible PEA PME), a next-generation biopharma ...